Crispr Therapeutics shares owned by Draper Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Draper Asset Management
from 13F filings
Historical chart of Draper Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Draper Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Draper Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $521k | 7.9k | 65.86 |
| 2023-12-31 | $675k | 11k | 62.60 |
| 2023-09-30 | $442k | 9.7k | 45.39 |
| 2023-06-30 | $551k | 9.8k | 56.14 |
| 2023-03-31 | $454k | 10k | 45.23 |
| 2022-12-31 | $535k | 13k | 40.65 |
| 2022-09-30 | $658k | 10k | 65.36 |
| 2022-06-30 | $703k | 12k | 60.75 |
| 2022-03-31 | $534k | 8.5k | 62.72 |
| 2021-12-31 | $554k | 7.3k | 75.76 |
| 2021-09-30 | $638k | 5.7k | 111.91 |
| 2021-06-30 | $776k | 4.8k | 161.97 |
| 2021-03-31 | $450k | 3.7k | 121.72 |
| 2020-12-31 | $269k | 1.8k | 152.84 |